Lindbrook Capital’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.39K Buy
+38
New +$1.31K ﹤0.01% 2385
2024
Q4
Sell
-235
Closed -$8.85K 2785
2024
Q3
$8.85K Hold
235
﹤0.01% 1737
2024
Q2
$9.3K Hold
235
﹤0.01% 1665
2024
Q1
$7.9K Hold
235
﹤0.01% 1686
2023
Q4
$7.83K Sell
235
-8
-3% -$258 ﹤0.01% 1666
2023
Q3
$7.63K Sell
243
-16
-6% -$503 ﹤0.01% 1544
2023
Q2
$8.21K Sell
259
-11
-4% -$355 ﹤0.01% 1584
2023
Q1
$8.92K Buy
270
+178
+193% +$5.83K ﹤0.01% 1516
2022
Q4
$2.96K Sell
92
-40
-30% -$1.36K ﹤0.01% 2058
2022
Q3
$5K Buy
132
+127
+2,540% +$5.27K ﹤0.01% 1635
2022
Q2
$0 Sell
5
-55
-92% -$2.67K ﹤0.01% 2482
2022
Q1
$3K Buy
+60
New +$3.28K ﹤0.01% 1785
2020
Q4
Sell
-116
Closed -$4K 1772
2020
Q3
$4K Hold
116
﹤0.01% 1153
2020
Q2
$5K Hold
116
﹤0.01% 1065
2020
Q1
$5K Buy
+116
New +$5.25K ﹤0.01% 967

Other funds holding ATEX

Lindbrook Capital's ATEX Position: Q1 2025 in Review

Lindbrook Capital opened a new position in Anterix (ATEX) in Q1 2025: 38 shares worth $1.39K. The stake represents ﹤0.01% of the portfolio and ranks #2385 among its holdings. This is a return to the name: Lindbrook Capital previously reported a position in ATEX as recently as Q3 2024.

Lindbrook Capital first reported a position in ATEX in Q1 2020 and has held it in 15 quarters since. The position peaked at $9.3K in Q2 2024. 128 funds tracked by Wall St. Rank hold ATEX as of Q1 2025.

  • Lindbrook Capital held 38 shares of Anterix worth $1.39K as of Q1 2025.
  • Anterix was a new Lindbrook Capital position in Q1 2025.
  • Anterix made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2385 holding.
  • Lindbrook Capital first reported a position in Anterix in Q1 2020 and has held it in 15 quarters since.
  • Lindbrook Capital's Anterix position peaked at $9.3K in Q2 2024.
  • 128 funds tracked by Wall St. Rank held Anterix as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.